Article Text

Download PDFPDF
Systematic review
Pooled results of two small trials with few events show a non-significant trend towards increased risk of intracerebral haemorrhage in people with Alzheimer's disease
  1. Barbara E Harrison
  1. Nurse Practitioner Programs, School of Nursing, Oakland University, Rochester, Michigan, USA
  1. Correspondence to Barbara E Harrison
    464 O’Dowd Hall, Oakland University, Rochester, Michigan 48309, USA; harriso3{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on: OpenUrlAbstract/FREE Full Text.

Alzheimer's disease and aspirin use

Alzheimer's disease (AD) is a neurodegenerative brain disease that leads to dementia. It is often accompanied by small vessel disease because of arteriosclerosis.1 AD and atherothrombosis share some common pathogenetic mechanisms which include chronic inflammation.2 Although the exact mechanism underlying this effect is still unknown, some have suggested aspirin use for patients with AD because of its anti-inflammatory properties.3 Thus aspirin use in AD has been considered by some researchers as a potential therapy for delaying the progression of AD through slowing of the neuroinflammatory response.4 …

View Full Text


  • Competing interests None.